Jim Cramer's Mad Money Stock Recap Sept. 28th
Alcatel-Lucent (ALU): Cramer thinks the CEO was given an ultimatum to deliver results now.
Marsh McLennan (MMC): The company should be broken up, and that splitting the company up is the only way shares will increase unless the CEO leaves.
Next, Cramer took some phone calls about other stocks with bad CEOs, like Pall (PLL). He also told people that he can't recommend buying Sirius (SIRI) now because it's too expensive, and that he thinks you should stay away from Palm (PALM).
Next, Cramer did a "Speculation Friday" segment, where he recommends high risk stocks. BioMarin (BMRN), a small biotech firm. It has developed a drug for pheylketonuria that will be the only drug on the market, protecting it from generic competition until 2015 in the US and 2018 in Europe. Cramer thinks the drug will be approved by the end of the year, but if it doesn't, it will be a risky investment.
Other calls: La-z-boy (LZB): Cramer doesn't like, and Sangamo BioSci (SGMO):He thinks is very risky.
After the lightning round, Cramer discussed what stocks he think will take the Dow to his year end target of 14,548. They are American Express (AXP), AIG (AIG), JPMorgan Chase (JPM), Citigroup (C), DuPont (DD), Altria (MO), Boeing (BA), and Caterpillar (CAT).
In the last segment, Cramer answered some emails. He changed his mind on GigaMedia (GIGM), making it a buy now, and told viewers to wait for a pullback on (AMZN) since it's "marked up heavily."
Labels: ALU, AMZN, AXP, BA, BMRN, CAT, DD, Jim Cramer, JPM, Mad Money, Mad MOney Recap, MMC, PALM, Pll, SIRI







